Related Experiment Video
Updated: Jul 18, 2026
08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
Efficient non-viral ocular gene transfer with compacted DNA nanoparticles.
Rafal Farjo1, Jeff Skaggs, Alexander B Quiambao
1Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America.
Plos One
|December 22, 2006
Summary
Compacted DNA nanoparticles offer a safe and efficient non-viral gene therapy for ocular tissues. Subretinal delivery effectively transfects photoreceptors, showing clinical viability for eye treatments.
Area of Science:
- Ophthalmology
- Gene Therapy
- Nanotechnology
Background:
- The eye's immune privilege and understood genetics make it ideal for gene therapy.
- Non-viral gene transfer systems are sought for ocular applications.
- Compacted DNA nanoparticles are safe, effective, non-immunogenic, and highly concentrated.
Purpose of the Study:
- To evaluate compacted DNA nanoparticles for non-viral gene transfer to ocular tissues.
- To assess the efficiency and targeting capabilities of these nanoparticles within the eye.
Main Methods:
- Varying injection sites to target different ocular tissues.
- Administering compacted DNA nanoparticles to eye tissues.
- Measuring gene expression levels post-transfection.
Main Results:
- Nanoparticles successfully transfected nearly all eye cell types in a dose-dependent manner.
- Subretinal delivery achieved high transfection rates in photoreceptors.
- Gene expression levels approached those of highly expressed native genes like rod opsin.
Conclusions:
- The nanoparticle-based gene delivery system is clinically viable for ocular tissues.
- No adverse effects on retinal function were observed.
- This technology provides an efficient and safe non-viral method for nucleic acid delivery to the eye.
